La Jolla, CA, United States of America

Mingxu Xu

This inventor holds 16 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignees: Anticancer, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mingxu Xu. Retrieved from https://idiyas.com/inventor/mingxu-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 50.0


Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • La Jolla, CA (US) (2005 - 2007)
  • San Diego, CA (US) (1997 - 2012)

Company Filing History:


Years Active: 1997-2012

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Mind of Mingxu Xu: Pioneering Cancer Research

Introduction

Mingxu Xu, based in La Jolla, California, is a notable inventor with an impressive portfolio comprising 16 patents. His innovative contributions primarily focus on advancing cancer research, particularly in the identification of biomarkers and the development of novel research models.

Latest Patents

Among his latest patents, one highlights methods for identifying markers for early-stage human cancer, cancer progression, and recurrence. This method outlines a process for identifying secreted proteins associated with cancer malignancy stages. These proteins are initially captured using a fluorescent protein-containing vector that can integrate into any gene. By utilizing fluorescence, the secreted proteins linked to specific tumor malignancy degrees are isolated to evaluate their potential as markers for cancer progression.

Another significant patent revolves around the use of immunocompromised rodents that express fluorescent proteins throughout their tissues. These modified rodents serve as valuable models for studying gene expression, tumor progression, and angiogenesis. The patent also includes systems where tissues that fluoresce in one color are transplanted into hosts that fluoresce in a different color, further enhancing research capabilities in this field.

Career Highlights

Mingxu Xu has made significant strides in his professional career, working with well-regarded organizations such as Anticancer, Inc. and the United States Department of Health and Human Services. His expertise has propelled forward key developments in cancer diagnostics and treatment methodologies, reflecting his commitment to improving patient outcomes.

Collaborations

Throughout his career, Xu has collaborated with esteemed colleagues, including Yuying Tan and Qinghong Han. These partnerships have fostered a rich environment for innovation, contributing to the advancement of cancer research and the development of effective therapeutic strategies.

Conclusion

Mingxu Xu's contributions to the field of cancer research through his patents emphasize his role as an influential inventor dedicated to enhancing our understanding of cancer and improving diagnostic techniques. His work continues to pave the way for future breakthroughs in medical research, illustrating the significant impact that one inventor can have in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…